Pulmonary arterial enlargement and acute exacerbations of COPD

J. Michael Wells, George R. Washko, Mei Lan K. Han, Naseer Abbas, Hrudaya Nath, A. James Mamary, Elizabeth Regan, William C. Bailey, Fernando J. Martinez, Elizabeth Westfall, Terri H. Beaty, Douglas Curran-Everett, Jeffrey L. Curtis, John E. Hokanson, David A. Lynch, Barry J. Make, James D. Crapo, Edwin K. Silverman, Russell P. Bowler, Mark T. Dransfield

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated loss of lung function and death. Identification of patients at risk for these events, particularly those requiring hospitalization, is of major importance. Severe pulmonary hypertension is an important complication of advanced COPD and predicts acute exacerbations, though pulmonary vascular abnormalities also occur early in the course of the disease. We hypothesized that a computed tomographic (CT) metric of pulmonary vascular disease (pulmonary artery enlargement, as determined by a ratio of the diameter of the pulmonary artery to the diameter of the aorta [PA:A ratio] of >1) would be associated with severe COPD exacerbations. METHODS:We conducted a multicenter, observational trial that enrolled current and former smokers with COPD. We determined the association between a PA:A ratio of more than 1 and a history at enrollment of severe exacerbations requiring hospitalization and then examined the usefulness of the ratio as a predictor of these events in a longitudinal follow-up of this cohort, as well as in an external validation cohort. We used logistic-regression and zero-inflated negative binomial regression analyses and adjusted for known risk factors for exacerbation. RESULTS:Multivariate logistic-regression analysis showed a significant association between a PA:A ratio of more than 1 and a history of severe exacerbations at the time of enrollment in the trial (odds ratio, 4.78; 95% confidence interval [CI], 3.43 to 6.65; P<0.001). A PA:A ratio of more than 1 was also independently associated with an increased risk of future severe exacerbations in both the trial cohort (odds ratio, 3.44; 95% CI, 2.78 to 4.25; P<0.001) and the external validation cohort (odds ratio, 2.80; 95% CI, 2.11 to 3.71; P<0.001). In both cohorts, among all the variables analyzed, a PA:A ratio of more than 1 had the strongest association with severe exacerbations. CONCLUSIONS: Pulmonary artery enlargement (a PA:A ratio of >1), as detected by CT, was associated with severe exacerbations of COPD. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov numbers, NCT00608764 and NCT00292552.)

Original languageEnglish (US)
Pages (from-to)913-921
Number of pages9
JournalNew England Journal of Medicine
Volume367
Issue number10
DOIs
StatePublished - Sep 6 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pulmonary arterial enlargement and acute exacerbations of COPD'. Together they form a unique fingerprint.

  • Cite this

    Wells, J. M., Washko, G. R., Han, M. L. K., Abbas, N., Nath, H., Mamary, A. J., Regan, E., Bailey, W. C., Martinez, F. J., Westfall, E., Beaty, T. H., Curran-Everett, D., Curtis, J. L., Hokanson, J. E., Lynch, D. A., Make, B. J., Crapo, J. D., Silverman, E. K., Bowler, R. P., & Dransfield, M. T. (2012). Pulmonary arterial enlargement and acute exacerbations of COPD. New England Journal of Medicine, 367(10), 913-921. https://doi.org/10.1056/NEJMoa1203830